SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0001140361-23-009281
Filing Date
2023-03-01
Accepted
2023-02-28 21:06:58
Documents
4

Document Format Files

Seq Description Document Type Size
1 FORM DEFR14A ny20007432x3_defr14a.htm DEFR14A 530920
2 logo_statera.jpg GRAPHIC 59986
3 ny20007432x3_pc01.jpg GRAPHIC 675670
4 ny20007432x3_pc02.jpg GRAPHIC 515268
  Complete submission text file 0001140361-23-009281.txt   2254085
Mailing Address 2537 RESEARCH BOULEVARD, SUITE 201 FORT COLLINS CO 80526
Business Address 2537 RESEARCH BOULEVARD, SUITE 201 FORT COLLINS CO 80526 (888) 613-8802
Statera Biopharma, Inc. (Filer) CIK: 0001318641 (see all company filings)

IRS No.: 200077155 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFR14A | Act: 34 | File No.: 001-32954 | Film No.: 23689249
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences